Hans Lennernäs
12Patents
3h-index
18Co-inventors
53Inventor score
Filing activity: Jun 8, 2001 → Jan 24, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6759059B1 | Fentanyl composition for the treatment of acute pain | Human Necessities | 110 | Expired |
| US8124118B2 | Composition comprising biodegradable hydrating ceramics for controlled drug delivery | Human Necessities | 54 | Active |
| US8556495B2 | Injector device | Human Necessities | 5 | Active |
| US9198884B2 | Use of carboxymethylcellulose to control ejectability and solidification time of compositions comprising one or more bioresorbable ceramics | Human Necessities | 1 | Active |
| US9925139B2 | Pharmaceutical compositions for acute glucocorticoid therapy | Human Necessities | 0 | Active |
| US10561617B2 | Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders | Human Necessities | 0 | Active |
| US11975105B2 | Modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders | Human Necessities | 0 | Active |
| US8936809B2 | Method for treating prostate diseases based on local delivery of active substances | Human Necessities | 0 | Active |
| US8425937B2 | Pharmaceutical compositions for glucocorticoid replacement therapy | Human Necessities | 0 | Active |
| US8999389B2 | Bioresorbable controlled-release composition | Human Necessities | 0 | Active |
| US10583146B2 | Pharmaceutical compositions for glucocorticoid replacement therapy | Human Necessities | 0 | Active |
| US9034359B2 | Composition comprising biodegradable hydrating ceramics for controlled drug delivery | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.